{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:34:48Z","timestamp":1787315688243,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral lichen planus (OLP) is a relatively common chronic T cell-mediated disease characterized by pain and inflammation. Clobetasol propionate (CLO) is the first-line drug in the treatment of OLP. The meta-analysis aimed to evaluate the efficacy and safety of CLO for treating patients with OLP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase and Web of Science were systematically searched from the database inception date up to August 2023. There were no restrictions on language or date of publication. The outcomes of our interest were as follows: improvement of clinical signs and\/or symptoms, total lesion size, relapse and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 17 RCTs evaluating the effects of CLO were included in this study. The results revealed no significant difference in the clinical score (WMD\u2009=\u20090.14, 95% CI: \u22120.39, 0.66;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.609) and pain score (WMD\u2009=\u20090.17, 95% CI: \u22120.44, 0.79;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.582) between CLO and other treatments. However, clinical resolution (RR\u2009=\u20091.61, 95% CI: 1.17, 2.22;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and symptoms improvement (RR\u2009=\u20091.80, 95% CI: 1.17, 2.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) were significantly different between CLO and other treatments. Moreover, there was a significant reduction in the total lesion size with CLO treatment (WMD\u2009=\u2009-0.58, 95% CI: \u22121.03, \u22120.13;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011). In addition, CLO showed no statistical incidence of adverse events (RR\u2009=\u20091.46, 95% CI: 0.86, 2.50;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.161) and relapse (RR\u2009=\u20091.56, 95% CI: 0.66, 3.71;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.314) than other therapies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis of 17 randomized clinical trials supported the long-term application of CLO as an effective regimen in OLP patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1391754","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:46:21Z","timestamp":1716511581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and safety of topical clobetasol propionate in comparison with alternative treatments in oral lichen planus: an updated systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Tao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChengYong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YeTong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeKe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/odi.14142","article-title":"Immune mechanisms in oral lichen planus","volume":"29","author":"El-Howati","year":"2023","journal-title":"Oral Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1600-0714.2008.00662.x","article-title":"The reported prevalence of oral lichen planus: a review and critique","volume":"37","author":"McCartan","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00403-016-1667-2","article-title":"Oral lichen planus: a literature review and update","volume":"308","author":"Alrashdan","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/odi.13323","article-title":"Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis","volume":"27","author":"Gonz\u00e1lez-Moles","year":"2021","journal-title":"Oral Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1601-0825.1999.tb00301.x","article-title":"The management of oral lichen planus","volume":"5","author":"Carrozzo","year":"1999","journal-title":"Oral Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.oooo.2015.01.025","article-title":"Quality of life in patients with oral potentially malignant disorders: a systematic review","volume":"119","author":"Tadakamadla","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2753.2009.01124.x","article-title":"Quality of life in patients with oral lichen planus","volume":"16","author":"L\u00f3pez-Jornet","year":"2010","journal-title":"J Eval Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12105-011-0318-3","article-title":"The dynamics of oral lichen planus: a retrospective clinicopathological study","volume":"6","author":"Kaplan","year":"2012","journal-title":"Head Neck Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1067\/mjd.2002.120452","article-title":"The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients","volume":"46","author":"Eisen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/odi.13812","article-title":"Oral cancer development in lichen planus and related conditions\u20143.0 evidence level: A systematic review of systematic reviews","volume":"27","author":"Ramos-Garc\u00eda","year":"2021","journal-title":"Oral Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.oraloncology.2019.07.012","article-title":"Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis","volume":"96","author":"Gonz\u00e1lez-Moles","year":"2019","journal-title":"Oral Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1601-0825.2008.01441.x","article-title":"Oral lichen planus: controversies surrounding malignant transformation","volume":"14","author":"Gonzalez-Moles","year":"2008","journal-title":"Oral Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tripleo.2004.06.076","article-title":"Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation","volume":"100","author":"Lodi","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3389\/fmed.2022.997190","article-title":"Therapeutic strategies for oral lichen planus: state of the art and new insights","volume":"9","author":"Didona","year":"2022","journal-title":"Front Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12903-024-04104-0","article-title":"Inflammatory cytokines mediating the effect of oral lichen planus on oral cavity cancer risk: a univariable and multivariable mendelian randomization study","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Oral Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/odi.14261","article-title":"Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus","volume":"29","author":"Al-Hallak","year":"2023","journal-title":"Oral Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14669","article-title":"CO2 laser vaporisation in treating oral lichen planus: A split-mouth randomised clinical trial","author":"Ibrahim","year":"2023","journal-title":"Oral Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/odi.14588","article-title":"Topical clobetasol treatment for oral lichen planus can cause adrenal insufficiency","volume":"30","author":"Einarsdottir","year":"2023","journal-title":"Oral Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1590\/S0365-05962010000500010","article-title":"L\u00edquen plano oral (LPO): diagn\u00f3stico cl\u00ednico e complementar","volume":"85","author":"Canto","year":"2010","journal-title":"An Bras Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1601-0825.1999.tb00063.x","article-title":"Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide","volume":"5","author":"Carbone","year":"1999","journal-title":"Oral Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1034\/j.1600-0714.2003.00173.x","article-title":"Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up","volume":"32","author":"Carbone","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"ED000142","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref27","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/ijp.ijp_984_20","article-title":"Comparative efficacy of topical coconut cream and clobetasol propionate ointment for the management of oral lichen planus: A double-blinded randomized control trial","volume":"54","author":"Mamadapur","year":"2022","journal-title":"Indian J Pharm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jop.13270","article-title":"Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trial","volume":"51","author":"Brennan","year":"2022","journal-title":"J Oral Pathol Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10006-022-01130-6","article-title":"Comparative evaluation of the efficacy of Nigella sativa (75% v\/v) cream and clobetasol propionate (0.05% w\/w) gel in oral lichen planus-a double-blinded randomized control trial","volume":"28","author":"Kumar","year":"2022","journal-title":"Oral Maxillofac Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/odi.13662","article-title":"Photobiomodulation is effective in oral lichen planus: A randomized, controlled, double-blind study","volume":"27","author":"Ferri","year":"2021","journal-title":"Oral Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18010056","article-title":"Analysis of the efficacy of two treatment protocols for patients with symptomatic oral lichen planus: A randomized clinical trial","volume":"18","author":"Santonocito","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/odi.12821","article-title":"Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus","volume":"24","author":"Arduino","year":"2018","journal-title":"Oral Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jicd.12237","article-title":"Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka","volume":"8","author":"Hettiarachchi","year":"2017","journal-title":"J Investig Clin Dent"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.4103\/0975-7406.191976","article-title":"A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus","volume":"8","author":"Sivaraman","year":"2016","journal-title":"J Pharm Bioallied Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"068002","DOI":"10.1117\/1.Jbo.19.6.068002","article-title":"Efficacy of laser phototherapy in comparison to topical clobetasol for the treatment of oral lichen planus: a randomized controlled trial","volume":"19","author":"Dillenburg","year":"2014","journal-title":"J Biomed Opt"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1365-4632.2012.05459.x","article-title":"Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial","volume":"51","author":"Sonthalia","year":"2012","journal-title":"Int J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ejpb.2010.07.014","article-title":"A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study","volume":"76","author":"Cilurzo","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-051X.2007.01191.x","article-title":"Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus","volume":"35","author":"Corrocher","year":"2008","journal-title":"J Clin Periodontol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tripleo.2007.07.029","article-title":"A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus","volume":"105","author":"Radfar","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2133.2005.06920.x","article-title":"Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial","volume":"154","author":"Conrotto","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1601-0825.1998.tb00289.x","article-title":"Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus","volume":"4","author":"Sardella","year":"1998","journal-title":"Oral Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/09546639409081837","article-title":"Erosive oral lichen planus treated with clobetasol propionate and triamcinolone acetonide in Orabase: A double-blind clinical trial","volume":"5","author":"Rodstrom","year":"1994","journal-title":"J Dermatol Treat"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1600-0714.2008.00688.x","article-title":"Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations","volume":"38","author":"Carbone","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"CD001168","DOI":"10.1002\/14651858.CD001168.pub3","article-title":"Interventions for treating oral lichen planus: corticosteroid therapies","volume":"2020","author":"Lodi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3390\/jcm12082763","article-title":"Comparative efficacy and safety of interventions for the treatment of Oral lichen planus: A systematic review and network Meta-analysis","volume":"12","author":"Leong","year":"2023","journal-title":"J Clin Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/odi.13790","article-title":"Efficacy of topical administration for oral lichen planus: A network meta-analysis","volume":"28","author":"Yuan","year":"2022","journal-title":"Oral Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/cancers12071949","article-title":"Photobiomodulation therapy in Oral mucositis and potentially malignant Oral lesions: A therapy towards the future","volume":"12","author":"Hanna","year":"2020","journal-title":"Cancers"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1391754\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:46:24Z","timestamp":1716511584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1391754\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":50,"alternative-id":["10.3389\/fmed.2024.1391754"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1391754","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"article-number":"1391754"}}